Sartorius Stedim Biotech S.A.
SDMHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $18,224,278 | $21,990,873 | $28,313,955 | $45,069,529 |
| - Cash | $678,900 | $116,600 | $107,100 | $223,626 |
| + Debt | $2,869,600 | $3,682,000 | $1,135,600 | $625,516 |
| Enterprise Value | $20,414,978 | $25,556,273 | $29,342,455 | $45,471,419 |
| Revenue | $2,780,000 | $2,775,500 | $3,492,700 | $2,886,977 |
| % Growth | 0.2% | -20.5% | 21% | – |
| Gross Profit | $1,206,700 | $1,233,500 | $1,834,500 | $1,553,003 |
| % Margin | 43.4% | 44.4% | 52.5% | 53.8% |
| EBITDA | $670,500 | $755,700 | $1,330,700 | $798,700 |
| % Margin | 24.1% | 27.2% | 38.1% | 27.7% |
| Net Income | $175,100 | $309,700 | $876,100 | $414,400 |
| % Margin | 6.3% | 11.2% | 25.1% | 14.4% |
| EPS Diluted | 1.81 | 3.36 | 9.51 | 4.5 |
| % Growth | -46.1% | -64.7% | 111.3% | – |
| Operating Cash Flow | $815,100 | $746,400 | $612,300 | $695,971 |
| Capital Expenditures | -$339,800 | -$473,600 | -$430,600 | -$323,987 |
| Free Cash Flow | $475,300 | $272,800 | $181,700 | $371,984 |